FRESENIUS MEDICAL CARE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.94 EUR | +1.78% |
|
+1.15% | -2.87% |
| 12:37pm | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Buy rating from Berenberg | ZD |
| 07-16 | Fresenius rises - Deutsche Bank: higher annual targets possible | DP |
| Sales 2024 * | 19.54B 21.35B 1,645B | Sales 2025 * | 20.28B 22.16B 1,708B | Capitalization | 10.65B 11.64B 897B |
|---|---|---|---|---|---|
| Net income 2024 * | 677M 740M 56.99B | Net income 2025 * | 969M 1.06B 81.57B | EV / Sales 2024 * | 1.04 x |
| Net Debt 2024 * | 9.72B 10.62B 818B | Net Debt 2025 * | 8.76B 9.58B 738B | EV / Sales 2025 * | 0.96 x |
| P/E ratio 2024 * |
15.9
x | P/E ratio 2025 * |
11
x | Employees | 117,128 |
| Yield 2024 * |
2.87% | Yield 2025 * |
3.58% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | +0.59% | ||
| 1 week | +0.14% | ||
| Current month | +2.07% | ||
| 1 month | -0.46% | ||
| 3 months | +0.19% | ||
| 6 months | +2.82% | ||
| Current year | -3.85% |
1 week
35.36
37.06
1 month
35.2037.06
Current year
33.8842.12
1 year
30.1649.62
3 years
25.9569.96
5 years
25.9581.10
10 years
25.9593.82
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 31/10/19 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 30/09/23 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 31/12/08 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 11/05/16 |
Shervin Korangy
BRD | Director/Board Member | 50 | 13/07/23 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 13/07/23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/07/24 | 36.87 | +1.57% | 130 262 |
| 17/07/24 | 36.3 | +0.69% | 296,141 |
| 16/07/24 | 36.05 | +0.39% | 252,421 |
| 15/07/24 | 35.91 | -2.47% | 329,012 |
| 12/07/24 | 36.82 | +1.02% | 274,637 |
Delayed Quote Xetra, July 18, 2024 at 01:02 pm
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
29/07/2024
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
36.3
EUR
Average target price
40
EUR
Spread / Average Target
+10.19%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.85% | 11.65B | |
| +19.32% | 84.59B | |
| -21.99% | 77.33B | |
| +0.70% | 27.12B | |
| -5.06% | 18.19B | |
| +7.77% | 18.49B | |
| +7.69% | 16.49B | |
| +76.20% | 13.55B | |
| +76.56% | 13.03B | |
| -27.54% | 12.43B |
- Stock Market
- Equities
- FME Stock
